Author Correction: Defective Sphingosine-1-phosphate metabolism is a druggable target in Huntington's disease

Affiliations

• ¹ IRCCS Neuromed, Pozzilli, Italy.
• ² Department of Drug Discovery and Development, Fondazione Istituto Italiano di Tecnologia, Genova, Italy.
• ³ Departments of Pediatrics, Neurology and Biochemistry, Vanderbilt University (VU) and VU Medical Center Pediatric Neurology Research Lab, Nashville, TN, USA.
• ⁴ John van Geest Cambridge Centre for Brain Repair, Department of Clinical Neuroscience, University of Cambridge, Cambridge, UK.
• ⁵ Institute of Biosciences and Bioresources (IBBR), National Research Council (CNR), Naples, Italy.
• ⁶ Department of of Cosmetic Science, Seowon University, Cheongju, Korea.
• ⁷ NeoPharm USA Inc. Engelwood Cliffs, New Jersey, USA.
• ⁸ Institute of Genetics and Biophysics "A. Buzzati-Traverso", Naples, Italy.
• ⁹ IRCCS Neuromed, Pozzilli, Italy. [email protected].